This condition leads to activation of the sympathetic nervous system. 2 A number of phenomena resulting from apnea have been shown to contribute to the increase of sympathetic nerve activity (SNA), for instance, chemoreceptor activation by hypoxemia 3,4 and hypercapnia, 5, 6 respiratory effort caused by breathing against an obstructed upper airway 7, 8 and arousal from sleep. 9,10 Consequently, increased SNA plays an important role for generation of hemodynamic changes associated with apnea. 3, [11] [12] [13] Arousal in OSA is likely to increase sympathetic outflow to the heart, splanchnic area, kidneys as well as the muscle and skin vascular beds. This will lead to elevation of heart rate, widespread vasoconstriction and increased blood pressure (BP). 14 However, the temporal characteristics and relative alteration of SNA in each of those vascular regions after apnea and arousal remains unclear. For instance, muscle SNA decreases at the resumption of breathing 2,3 while skin SNA seems to peak during the period following apnea coinciding with arousal. 15 Decreased muscle SNA is proposed to result from activation of baroreceptors 16 and pulmonary stretch receptors (lung volume). 17, 18 On the other hand, skin SNA is not baroreflex modulated 19 and may be augmented by hyperventilation after the apnea termination. 20 Therefore, it is likely that skin SNA provides a better measure of arousal related autonomic nervous activity changes in sleep-disordered breathing.
INTRODUCTION
OBSTRUCTIVE SLEEP APNEA (OSA) IS CHARACTERIZED BY RECURRENT AIRFLOW CESSATION WITH CYCLIC HYPOX-EMIA, HYPERCAPNIA AND TRANSIENT AROUSALS. 1 This condition leads to activation of the sympathetic nervous system. 2 A number of phenomena resulting from apnea have been shown to contribute to the increase of sympathetic nerve activity (SNA), for instance, chemoreceptor activation by hypoxemia 3, 4 and hypercapnia, 5, 6 respiratory effort caused by breathing against an obstructed upper airway 7, 8 and arousal from sleep. 9, 10 Consequently, increased SNA plays an important role for generation of hemodynamic changes associated with apnea. 3, [11] [12] [13] Arousal in OSA is likely to increase sympathetic outflow to the heart, splanchnic area, kidneys as well as the muscle and skin vascular beds. This will lead to elevation of heart rate, widespread vasoconstriction and increased blood pressure (BP). 14 However, the temporal characteristics and relative alteration of SNA in each of those vascular regions after apnea and arousal remains unclear. For instance, muscle SNA decreases at the resumption of breathing 2,3 while skin SNA seems to peak during the period following apnea coinciding with arousal. 15 Decreased muscle SNA is proposed to result from activation of baroreceptors 16 and pulmonary stretch receptors (lung volume). 17, 18 On the other hand, skin SNA is not baroreflex modulated 19 and may be augmented by hyperventilation after the apnea termination. 20 Therefore, it is likely that skin SNA provides a better measure of arousal related autonomic nervous activity changes in sleep-disordered breathing.
The skin vascular bed is involved in thermoregulation and there is reflex vasoconstriction in response to cold as well as vasodilatation in response to heat exposure. The digit skin vascular beds, nail bed and fingertip per se, are rich in arteriovenous anastomoses that enable enormous variation of skin blood flow. A considerable part of this variability appears to be controlled by skin sympathetic fibers. Peripheral arterial tonometry (PAT), a new finger plethysmography technique, was recently introduced to monitor digital vascular response to sleep and related disorders. 15, [21] [22] [23] [24] It continuously measures the pulsatile volume change (optical density changes from palmar surface of the finger) using a pnenumo-optic probe, which reflects to the relative change of blood volume in the finger. 15, 21 The PAT signal was substantially attenuated during resumption of ventilation after airflow obstruction and hypoxemia, and mainly coinciding with arousal. 25 Therefore, PAT has been proposed to provide a method for noninvasive assessment of SNA in the digital vascular bed during obstructive apneic events.
We have previously demonstrated that pulse wave amplitude derived from finger plethysmography dose dependently decreased after norepinephrine (α-receptor agonist) given by brachial artery infusion during wakefulness. 26 The present study was undertaken to characterize the digital skin vascular response (PAT signal amplitude change) to spontaneous obstructive breathing events in patients with OSA. We hypothesized that pulse amplitude attenuation reflecting the digital vasoconstriction following apnea during nonrapid eye movement (NREM) sleep was mainly α-adrenoreceptor mediated.
METHODS

Subjects
Eight male patients with documented severe OSA were recruited from the Sahlgrenska University Hospital Sleep Laboratory and studied. Patients were nonsmokers and free of peripheral vascular disease, diabetes mellitus and hypercholesterolemia. None of the patients received vasoactive medication on a regular basis. The study protocol had been approved by the Human Research Ethics Committee, Sahlgrenska University Hospital. Written informed consent was obtained from each participant prior the study.
Study Procedure
After physical examination and assessment of forearm volume, a 20-gauge polyethylene catheter (Ohmeda, Swindon, UK) was inserted into the brachial artery of the non-dominant arm under sterile conditions after local anesthesia (lidocaine 1%). The catheter was connected to a DPT-6000 pressure transducer (PVB medizintechnik GMBH, Kirchsee, Germany) and intermittently flushed with 0.9% saline using a three-port connector placed in series with the catheter-transducer system. All patients underwent a single overnight polysomnography (PSG) recording with a minimum 6-hour sleep time in a temperature-controlled environment (21°C). Electrode placement and sensor application for standard PSG were prepared including electroencephalogram (EEG), electrooculogram, chin and anterior tibialis muscle electromyogram and electrocardiogram. Ventilatory monitoring included nasal pressure cannula, oronasal thermistor, thoracic and abdomen respiratory effort belts, position sensor and finger pulse oximetry. The PAT (Sleep PAT 200, Itamar, Caesarea, Israel) probe was placed on ring finger of the infusion arm to measure the pulsatile arterial volume change in the digital vascular bed. The intraarterial BP signal from the brachial artery and the PAT signal were digitized at a frequency of 100 Hz and continuously fed into the PSG system (EMBLA, Flaga, Reykjavik, Iceland).
Baseline data collection and infusion procedures took place no earlier than after 30 minutes of continuous sleep and after the subjects had demonstrated a sustained pattern of repetitive obstructive apnea/hypopnea events. The protocol therefore aimed at undertaking all measurement according to an approximately similar real time basis, but slight deviations between individual recordings did occur due to variable time until sleep onset.
The combined α 1 and α 2 receptor antagonist phentolamine (Regitin®, Novartis, Bern, Switzerland) was infused intraarterially at three dose steps corresponding to 0.066, 0.2 and 2 µg/min/100ml forearm volume each of twenty minutes. A minimum of 20 minutes sleep was allowed between each infusion step. An additional fourth dose of phentolamine corresponding to 5 µg/min/100ml forearm volume was added in the last three patients for 20 minutes in order to better distinguish a ceiling effect of the dose-response curve. Due to the escalating dosing procedure, we did not randomize the intervention order in the study.
Data Analysis and Statistics
Sleep stage and arousal were manually scored according to standard criteria. 27, 28 The EEG frequency shift of arousal was defined lasting at least 3 seconds. An obstructive apnea/hypopnea event was defined as a > 50% amplitude reduction of airflow compared to baseline or an evident airflow reduction associated with either an oxygen desaturation of > 3% or an EEG arousal. 29 A minimum duration requirement for all recorded events was 10 seconds. The apnea/hypopnea index was calculated as the total number of apneas and hypopneas per hour total sleep time. The arousal index was expressed as the number of arousals divided by total sleep time.
Apnea/hypopnea events with arousals classified in NREM sleep during each experimental step were isolated and exported via the PSG program (Somnologica 3.0, Flaga, Reykjavik, Iceland) for further analysis using custom software developed in the laboratory. Pulsatile amplitudes (trough to peak) assessed from PAT were determined during and for 21 seconds following each event. The change in pulse amplitude across the apneic/hypopneic event including the post-apnea/hypopnea period was calculated separately for each event and expressed as the PAT ratio (multiplied by 100). This was defined as the mean of the three smallest consecutive PAT pulse amplitudes in the 21-second post-apnea/hypopnea period divided by the mean of the three largest consecutive amplitudes during the apnea/hypopnea itself. The vascular effects of each level of phentolamine infusion on PAT ratio were analysed using linear mixed effects regression models with paired individual intervention contrasts with the baseline. 30 The mean systolic, diastolic BP and pulse rate of the apneic/hypopneic event and the post apneic/hypopneic period were calculated at baseline and immediately after termination of phentolamine infusion, respectively. Mean arterial pressure (MAP) at each event/post-event period was calculated separately according to formula MAP = (systolic pressure -diastolic pressure) / 3 + diastolic pressure. The mean of MAP and pulse rate at baseline and following interventions were compared within each subject using paired sample t-test. Differences with a p-value less than 0.05 were considered as significant. The data are reported as means ± SE.
RESULTS
Eight male OSA patients were enrolled in the study. The characteristics of study subjects and PSG data are shown in Table 1 . The pulsatile volume signal assessed from PAT displayed periodical attenuation after spontaneous apnea/hypopnea events coinciding with arousals. The mean PAT ratio at baseline was 33.9 ± 3.8% suggesting a considerable attenuation of pulse amplitude in the post-event phase. A typical recording from one patient demonstrates the PAT amplitude changes during different experimental steps (Figure 1) . A dose-dependent increase in PAT ratio with a threshold above 0.066µg was demonstrated during the cumulative dose administration of phentolamine ( Figure 2 ). The PAT ratio increased with 11.2 ± 1.7%, 24.4 ± 2.1%, and 30.9 ± 4.1% compared with baseline after the three higher concentration steps of phentolamine (0.2, 2 and 5µg P < 0.001, respectively). MAP decreased 5.3 ± 0.3 mmHg (P = 0.04) during the apnea event at the 5µg concentration level of phentolamine. Post-event pulse rate was lower 2.7 ± 1.0 beats/min (P = 0.033) after phentolamine 2µg infusion compared to baseline (Table 2) .
Altogether 1036 obstructive apnea/hypopnea events during NREM sleep (mainly sleep stage 1 and 2) were analyzed in the study (baseline n = 350, phentolamine 0.066µg n = 202, 0.2µg n = 190, 2µg n = 202, 5µg n = 92, respectively). Mean event length compared with baseline was unchanged during all the interventions. There were small and inconsistent differences in oxyhemoglobin desaturation between baseline and phentolamine infusion mainly due to spontaneous variation.
DISCUSSION
The present study demonstrates that the digital pulse amplitude determined by tonometry is attenuated in response to obstructive breathing events during sleep. The finger pulse amplitude response to apnea is antagonized by the α-receptor antagonist phentolamine in a dose dependent manner indicating that obstructive apneic events induce α-receptor mediated digital vasoconstriction. The results extend our previous finding that a lower pulse wave amplitude following norepinephrine infusion reflected reduction of finger blood flow in awake spontaneously breathing subjects. 26 Alpha Assessments of skin blood flow by methods including radioisotope administration, plethysmography and laser Doppler velocimetry are technically limited by the influence of underlying subcutaneous tissue. Nevertheless, a close correlation between blood flow and pulse volume in the finger was earlier demonstrated by Burton using finger plethysmography. 31 More recent studies 32, 33 suggest that both digital blood flow and pulse volume are influenced by the vasomotor tone. A possible explanation could be that arteriovenous anastomoses in the finger are predominantly controlled by sympathetic vasoconstrictor neurones capable of regulating the majority of total digital blood flow. 34 The finger plethysmographic technique used in this study applied a uniform pressure field in the fingertip 21 in order to avoid local venous distension caused vasoconstriction. 35 It is therefore likely that PAT, by reflection of pulsatile volume signals from the fingertip, can provide a sensitive marker for assessment of skin SNA during OSA. We therefore decided to define the underlying characteristics of the digital vasoconstriction (PAT amplitude attenuation) associated with spontaneous obstructive breathing events during sleep.
Skin blood flow measurements are relative. During normal resting conditions, cutaneous blood flow fluctuates in response to autonomic sympathetic activity in a manner that varies within and between individuals as well as in response to ambient temperature and circadian rhythm. 31, 33, 34, 36 Such fluctuations were also likely to occur in the present study and they may to some extent have influenced the assessments. In order to more accurately reflect the relative flow change in the digital vascular bed associated with OSA, we therefore applied a ratio component (PAT ratio). It should be noted that for instance an increased PAT ratio in this pharmacological intervention study could have occurred as a consequence of an increase in PAT amplitude during the post-event phase, a decrease of amplitude during the event or a combination of the two. However, the amplitude appeared to change only marginally during the event and the increase in PAT amplitude during the post-event period seemed to mainly account for the increasing PAT ratio following phentolamine infusion. It therefore appears plausible that α-receptor mediated vasoconstriction of the digital skin vascular bed is a prominent phenomenon associated with the termination of events. Although hard to exactly determine, there was an approximate time delay in the order of 3-7 seconds from the start of electrophysiological arousal to the onset of pulse amplitude attenuation most likely reflecting latency caused by a delay at the vascular target tissue level. A 21-second time window during the post event period was applied in order to cover all the amplitude attenuation related to the event.
Our data suggests that the reversal of pulse amplitude attenuation during the post apnea period is mainly due to vascular α-receptor blockade. Phentolamine has previously been demonstrated to increase finger blood flow during body cooling while nitroprusside, a direct smooth muscle dilator, was ineffective. 37 Thus, in this model of sympathetically induced digital vasoconstriction, phentolamine exerted α-receptor antagonistic properties rather than a nonspecific vasodilator response. Moreover, the effect of phentolamine was dose dependent but the attenuation of the constrictory response was incomplete at the highest dose level applied. This incomplete reversal of the vascular response could suggest that other vascular tone modulators contribute to digital vasoconstriction following apnea. The exact nature of such potential contributors remains to be determined and studies are needed to fully elucidate such influences in apnea induced digital vasoconstriction.
Sympathetic nervous activation is associated with a highly differentiated response to various vascular beds. 38 Conditioning of the autonomic response suggests that the digital vascular changes in this study can not readily be extended to other sympathetic effector systems. For instance, in sleep apnea skin SNA reflected by PAT amplitude, peaked at postapneic period when muscle SNA is known to be almost completely suppressed. The reason for this disassociation is unknown. A possible explanation would be the apnea associated physiologic changes have different effects on target organs. The arousal response may inhibit muscle SNA during post apnea 16 and simultaneously provoke skin SNA (PAT amplitude attenuation). 25 Whether other changes (hypoxemia, hypercapnia, heart rate increase, BP elevation, lung stretch-receptor activation) during apnea also contribute to this differentiation needs to be further investigated.
Limitations of the study
The study was limited by small number of investigated subjects. Only NREM sleep was analyzed in the study due to the proportionally small amount of rapid eye movement sleep in the subjects. Two subjects demonstrated only a minimal response to phentolamine infusion. It is possible that these subjects had an altered adrenergic α-receptor sensitivity as previously demonstrated in OSA patients. 39 Other data suggested that age might influence the α-adrenergic vascular response 40 but this was not substantiated in the present study. Finally, it cannot be excluded that minor local alteration of blood pressure may have influenced the PAT response characteristics. Phentolamine is known to induce longlasting vascular effects. 36 There was a slight reduction of arterial blood pressure measured in the ipsilateral peripheral vascular bed during peak dosing of phentolamine. However, this effect was unlikely to have influenced the main effect of α-adrenergic vascular activation during arousal as similar effects of phentolamine were seen already at lower dose levels not affecting blood pressure. Moreover, the general hemodynamic influence on skin SNA is likely to be negligible. 19 In conclusion, pulse amplitude in the digital vascular bed is attenuated during the immediate post-apnea period. The extent of attenuation was dose dependently influenced by the α-receptor antagonist phentolamine. The findings suggest an important adrenergic α-receptor mediated mechanism in this response. Although this arousal related digital vasoconstriction is a prominent feature during obstructive sleep disordered breathing events, it may be largely unrelated to the systemic hemodynamic changes associated with OSA. 
